Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

An Open-label, Dose-escalation Phase Ib Study of EA5 Injection in Adults With Anti-AChR Antibody-Positive Generalized Myasthenia Gravis

Shanghai Lanyi Therapeutics Co., Ltd. · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
generalized myasthenia gravis (gmg), ea5, generalized myasthenia gravis, complement c5 inhibitor, phase ib, anti-achr, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 876868
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.